key: cord-0069983-jzfbg7pa authors: Javidfar, Jeffrey; Zaaqoq, Akram M.; Yashimata, Michael H.; Eschen, Greg; Jacobs, Jeffrey; Heinsar, Silver; Hayanga, Jeremiah W.; Peek, Giles; Arora, Rakesh title: Venovenous extracorporeal membrane oxygenation in obese patients date: 2021-10-28 journal: JTCVS Tech DOI: 10.1016/j.xjtc.2021.08.048 sha: 5f2415f2d5c2245b245c5e16ada4fca155597c52 doc_id: 69983 cord_uid: jzfbg7pa nan Feature Editor's Note-The use of venovenous (VV) extracorporeal membrane oxygenation (ECMO) has experienced broader adoption over the preceding decade for the management of respiratory failure. As experience with VV-ECMO has grown, VV-ECMO has been applied to more patients afflicted with a greater burden of comorbidities, which has been particularly evident during the global COVID-19 pandemic. One of the more common comorbidities is that of obesity. The use of VV ECMO in obese patients poses significant challenges and requires adoption of different techniques to achieve adequate respiratory support and successful outcomes. In this Invited Expert Technique article, Javidfar and colleagues review respiratory management and VV-ECMO techniques for application in obese patients. The authors discuss optimal respiratory management practices including use of esophageal pressure monitoring to assess lung pressures and special considerations in use of prone positioning. Optimal cannulation techniques are reviewed as well as techniques to obtain optimal ECMO flow, gas exchange and oxygenation, and facilitate airway management and physical therapy. Importantly, the authors review thresholds and situations in which conversion to veno-arterial ECMO might be necessary. Javidar and colleagues should be congratulated on a timely, insightful, and comprehensive review on the topic VV-ECMO for respiratory failure in obese patients and for providing an excellent guide to achieving optimal outcomes. Francis D. Pagani, MD, PhD Historically, obesity was not considered a major risk factor for adverse outcomes in patients with acute respiratory distress syndrome (ARDS). Commonly extracorporeal membrane oxygenation (ECMO) survivability prediction scores (ie, Respiratory Extracorporeal Membrane Oxygenation Survival Prediction score) do not consider obesity as a risk factor. 1,2 Indeed, obesity typically decreased the risk of mortality. However, in patients with COVID-19, obesity (body mass index [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] and severe obesity (body mass index >40) are considered risk factors for poor outcomes related to acute hypoxemic respiratory failure (Table 1) . 3, 4 Venovenous (VV) ECMO has been used increasingly in the management of ARDS secondary to severe acute respiratory failure coronavirus-2. Safe vascular cannulation and adequate blood flow generation through the ECMO circuit are potentially serious obstacles for health care teams caring for obese COVID-19 patients. We seek to provide an Q2 expert review of an approach to the obese patient requiring VV ECMO. Obesity is characterized by anatomical and physiological alterations that negatively affect pulmonary and cardiovascular function in critically ill patients. Obese patients are disproportionately susceptible to hypoxemia from chronic ventilation/perfusion mismatch. 5 Increased chest wall mass and intra-abdominal pressure also contribute to a decrease in functional residual capacity. 6 This might lead to an increase in pulmonary vascular resistance over time. Furthermore, patients with class 2 and 3 obesity have a higher resting oxygen consumption. 7 To meet the increased oxygen demands and to perfuse the excess body mass, obese patients have increased cardiac output and blood volume. 8 In normotensive obese patients, elevated cardiac output is associated with low peripheral vascular resistance and increased left ventricular enddiastolic pressure. 9 Finally, patients are susceptible to obesity hypoventilation syndrome, obstructive sleep apnea, secondary pulmonary hypertension, and right ventricular failure. 10 Mechanical ventilation in patients with class 2 and 3 obesity and ARDS should be approached in a different manner than patients with a normal habitus. 11 The higher intra-abdominal pressures of obese patients can be countered with the use of reverse Trendelenburg position, which contributes to a decrease in transpulmonary pressure (P tp ). It is also imperative to use the minimal fraction of inspired oxygen to achieve the required partial pressure of oxygen (PaO 2 ) of 55 to 80 mm Hg. Studies have shown that hyperoxemia is associated with increased mortality in critically ill patients. 12, 13 Especially for obese patients, hyperoxemia can exacerbate the already existing chronic inflammation associated with poor outcomes. 14 Obese patients with ARDS can be optimized with low tidal volume of 4 to 6 cc/kg on the basis of predicted body weight and plateau pressure<30 cm H 2 O. 15 However, it is important to emphasize that lung size does not change with body weight, and tidal volumes should not be on the basis of actual body weight. Lower driving pressures have been linked to improved survival in patients with ARDS. 16, 17 However, this benefit did not carry over in the obese population likely because of difficulties with accurate pressure measurements. 18 In patients with class 2 and 3 obesity, P tp can be most accurately calculated using esophageal pressure monitoring. The compliance of the respiratory system represents the combined compliance of the chest wall and the lungs. In patients with class 2 and 3 obesity, a sizeable fraction of applied positive end-expiratory pressure (PEEP) may be diverted to lifting the heavier chest wall and overlying subcutaneous tissue off of the lungs with little actual effect on P tp . This might lead to mechanical ventilation-induced lung injury from repetitive opening and closing of alveoli at low lung volumes (atelectrauma). Conversely, the blind application of high levels of PEEP might result in alveolar overdistension at end inspiration (barotrauma), as well as adverse cardiovascular consequences (Table E1) . The use of an esophageal balloon can effectively titrate PEEP to increase lung compliance and improve arterial oxygenation in patients with ARDS 19 (Figure 1 ). However, a definitive survival benefit has not yet been shown using this technique in patients with severe ARDS. 20 Two assumptions are inherent. Esophageal pressure equates with pleural pressure, and pleural pressure is uniform throughout the hemithorax. 21 After the esophageal balloon is correctly calibrated and positioned, P tp can easily be displayed on the ventilator monitor. This allows the bedside clinician to visually inspect the true pulmonary distending pressures at any given time. Applied PEEP is then titrated in 2-cm H 2 0 increments to maintain a P tp PEEP of > 0 cm H 2 O to mitigate against atelectrauma while ensuring the P tp plateau remains <20 cm H 2 O to avoid barotrauma (Table E2) . Although the esophageal balloon Q3 has its limitations, in patients with class 2 and 3 obesity, it is reasonable to use it to optimize PEEP and PaO 2 before committing to VV ECMO. Prone positioning improves oxygenation by enhancing ventilation/perfusion matching by providing a more homogenous distribution of P tp throughout the lungs. 22 It either directly enhances lung compliance or indirectly improves it by reducing body wall compliance. 23 In patients with severe ARDS, early proning is associated with reduced mortality. 24 Prone positioning in obese patients has showed an improved PaO 2 :fraction of inspired oxygen ratio without higher complication rates 25 ( Figure E1 ). Before proning, it is important to develop a bedside checklist and to have well-trained staff with clear assignment and roles. Obese patients might be exposed to pressure injuries so adhesive pads should be applied to forehead, chest, iliac crests, and knees. Also, special head support devices can reduce the incidence of skin ulceration of the face. Automated proning beds have the advantage of requiring fewer staff and can facilitate rapid return to supine position (Table E3) . When managing the morbidly obese patient in whom conventional management is failing, ECMO support should be considered. The safe placement of the ECMO cannulas requires specific surgical expertise that can be beyond the capabilities of centers with lower ECMO case volume or experience. 26 It might be prohibitive if cannulation is being contemplated remotely at a satellite hospital (Table E4) . There are general principles of cannulation for obese patients, particularly those with class 3 obesity. First, because of habitus, there is an alteration of anatomical landmarks. In these situations it is most beneficial to use 2-view, real-time ultrasound guidance to access the vessels. 27, 28 Because of the increased amount of soft tissue, the vessels tend to be deeper from the surface and vascular access might require longer access needles and sheaths. One might need to use steeper angles for vascular access and during percutaneous soft tissue dilation ( Figure 2 ). The risk of guide wire kinking during cannulation is increased. One must maintain a low threshold to exchange and use fresh and/or stiffer wires when needed. The latter requires image guidance to minimize risk of vessel injury or rupture, and can be placed using exchange catheters even at the bedside. To further mitigate against kinking of the wire, the proceduralist should keep the needle angle as shallow as possible when initially accessing the vessel. Using longer, more gently tapered silicone dilators might also be useful. To assist with safe cannula placement, a second point of image guidance in the form of radiograph and/or cardiac echo (transthoracic or transesophageal) should be used. Last, using 2 cannulas has the theoretical advantage of offering increased ECMO flows while minimizing hemolysis. In the interest of maximizing flows, use as large of a drainage cannula as possible to avoid high venous pressures 29 (Table 2 ). This not only facilitates enough gas exchange initially to support an obese patient, but provides a buffer of excess flow that allows for diuresis later in the patient's ECMO management course ( Figure E1 ). Use of the largest available drainage cannula should be considered during initial cannulation. If additional flows are needed, a third cannula can be placed either in the remaining femoral vein or an upper body vein to allow for a "VVV" configuration with bicaval drainage (Figure 3 , A). Alternatively, the lungs can be bypassed with a venoarterialvenous (VAV) ECMO configuration. There are specific pros and cons to the various configurations of VV ECMO in the class 2 and 3 obese patient (Table 3 ). If partial cardiac support is required then VAV ECMO offers the added benefit of partial cardiac support (Table 4 ). Even with the use of ultrasound, accessing the cervical vessels might be challenging. The right internal jugular (IJ) vein tends to be the easiest site for peripheral cannulation in this population because it is anatomically in line with the superior vena cava. This can be for either a singlesite dual lumen cannula or as part of a femoral-IJ configuration. A dual lumen cannula has the benefit of requiring only a single vascular puncture, but should only be placed by experienced cannulators using the requisite image guidance to prevent vascular or cardiac injury. This necessitates the availability of image guidance in the intensive care unit or that the patient is stable enough for transportation to the operating room or catheterization lab. Maximum flows tend to be approximately 4.5 liters per minute (LPM), and this might be insufficient to support the class 2 and 3 obese patient in the acute phase of their ARDS. 30 However, a duallumen cannula has the advantages of obviating the need for a femoral cannula, which can facilitate patient mobilization, easier rehabilitation, and increase patient comfort. 31 Femoral cannulation, femoral-femoral, or femoral-IJ configuration can be used. Two cannulation sites have the advantage of greater flows due to enhanced drainage versus a single-site, dual-lumen cannula. However, a large pannus and significant amount of subcutaneous tissue can make femoral cannulation challenging. To mitigate against challenges such as kinking of guide wires and difficulties with serial dilation one should take care to meticulously retract the pannus in a secure fashion before prepping and draping. The preferential use of the right groin might be advisable because the right femoral vein is anatomically more in line with the inferior vena cava. However, bifemoral cannulation can be performed safely at the bedside, and, if used with image guidance, offers a low risk of recirculation ( Figure 3, B) . If the patient does not require high flows, IJ vein or left subclavian vein cannulation with a dual-lumen cannula might offer the advantage of obviating the need for a femoral cannula, facilitating mobilization and freeing up a peripheral venous access site (Figure 3 , C). The left subclavian vein has the added advantage of being further away from the tracheostomy site and less likely to be soiled by its secretions. Because of the anatomy and habitus, radiographic guidance should be routinely used for all duallumen cannulations. The primary goal of VV ECMO is to provide adequate gas exchange and oxygenation while allowing the lungs time to recover. Oxygenation depends on rate of flow, hemoglobin concentration, oxygenator surface area, and the fraction of inspired oxygen of the gas flow. To maximize oxygen delivery, high ECMO flow (6-7 LPM) is needed, which is dependent on cannula size, position, and patient volume status. Elevating serum hemoglobin levels can increase blood oxygen content. 32 Finally, increasing oxygenator surface area by using 2 oxygenators in parallel can improve oxygenation and gas exchange. 33 The pharmacokinetics in obese patients receiving ECMO has not been wellstudied. However, the literature shows that differences in opioid and benzodiazepine requirements were not as great as initially predicted for obese versus nonobese patients receiving VV ECMO. 34 Obese patients can be difficult to manage in the critical care setting. Prone positioning of obese patients receiving VV ECMO has specific pitfalls. Most concerning, are accidental decannulation, extubation, or removal of invasive lines from the patient. However, in experienced centers many of these complications tend to be avoided. 35 Proning patients receiving ECMO is also labor-intensive and can lead to staff injuries. Furthermore, proning obese patients receiving VV ECMO can increase intra-abdominal pressures and impair ECMO flows. Finally, as discussed previously, class 2 and 3 obese patients are at an increased risk of cannula kinking, skin breakdown, and pressure ulcer formation. Tracheostomy in the ECMO population is considered safe. 36 After patients are receiving ECMO, each center should continue to follow its established protocols and guidelines for airway management including timing and surgical approach to tracheostomy. When possible, early tracheostomy should be considered. The use of extra-long tracheostomy tubes should be considered to minimize the risk of dislodgement, fistula formation, and tracheal injury. 37 Patients with class 2 and 3 obesity who require VV ECMO are at particular risk for critical illness myopathy and muscle loss. Mobilization also poses a challenge. Practical risks include kinking of lower body cannulas due to the pannus as a result of the angle that the femoral cannula travels through the soft tissue. 38, 39 In instances in which 2 or more sites of cannulation are required, physical activity might be limited to bed exercises, such as active and passive range of motions activities. It is important to firmly secure the cannula and tubing to the skin with suture and attachment devices. Usually bed-based pedal bikes can be logistically prohibitive because of the habitus and ergonomics. Patients may sit up in a bed converted to the chair position. Tilt table beds specially designed for physical therapy allow for standing and weight-bearing. They can be used to build core strength without flexion at the hips. It is easier to mobilize patients who can solely be supported using upper body dual-lumen cannula. 40, 41 As ECMO flow requirements decrease below 4 to 4.5 LPM, a patient can be converted to a dual-lumen cannula, and out of bed exercises can begin. This can include dangling, sit to stand, and then walking on portable treadmills. Patients can also strengthen their core by spending hours a day sitting in a chair. At the peak of their physical therapy training patients can walk laps in the intensive care unit (because they are usually off of isolation precautions by this point). Stationary bikes may also be used. Patients with class 2 or 3 obesity tend to be hypercoagulable in part due to the higher inflammatory state. This, when possible, calls fora higher degree of anticoagulation. There is also a trend toward bivalirudin usage in lieu of heparin for daily anticoagulation management in VV ECMO patients. Intravenous bivalirudin has been associated with decreased number of ECMO circuit-related thrombotic events and decreased blood transfusions compared with unfractionated heparin drip. 42 In practice, this can still include a heparin bolus of 5000 to 8000 units for cannulation. The initial use of heparin is on the basis of practicality and availability in patients with emergency or remote cannulations. However, it is dosed at a higher level than for nonobese patients. For maintenance, patients can be transitioned to a bivalirudin drip with activated partial thromboplastin time (aPTT) monitoring. The dosing is managed with a nomogram with a starting aPTT goal of 60 to 80 seconds. Alternatively, a heparin drip with a Factor Xa or an aPTT monitoring nomogram can be used. The anticoagulation should be titrated depending on instance and severity of events such as intracranial bleeding, gastrointestinal bleeding, and bleeding from the naso/oro pharynx or tracheostomy site. Additional benefits of bivalirudin include a short half-life, easy monitoring, and avoidance of heparininduced thrombocytopenia and/or antithrombin III deficiency. All post-ECMO patients with class 2 or 3 obesity would benefit from 4-limb surveillance ultrasound examination, because some might need continued post ECMO anticoagulation. JTCVS Techniques c Volume -, Number -5 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 The pre-and peri-ECMO phases are usually when patients with refractory respiratory failure are the most hemodynamically unstable. They usually have significant acid-base disarray, and can require high doses of multiple pressors and/or ionotropes. Maximal ventilator support might fail, which includes high PEEP levels that can diminish venous return. In this situation, patients are vulnerable to varying degrees of right heart failure that can be made worse by the physiologic changes associated with class 2 and 3 obesity. If significant hemodynamic instability is being experienced, additional right heart support can be derived from inhaled pulmonary vasodilators (such as nitric oxide and epoprostenol sodium) and/or ionotropes. In our experience in obese class 2 and 3 patients with isolated respiratory failure severe right heart failure is transient. Significant hemodynamic benefits can be derived from VV ECMO alone without directed mechanical support of the right heart. VV ECMO allows for a rapid correction of pH and improvement in pharmacokinetics because enzymes and medications tend to work optimally at a normal pH. As the ventilator is weaned further toward rest settings, a normalization of the previously very high PEEP improves venous return. Often after a brief period of VV ECMO, pressors, ionotropes, and the ventilator can all be weaned as the patient's hemodynamics stabilize. However, if patients VV ECMO plus inhaled pulmonary vasodilator and ionotropes fail, then several mechanical options are available. The first would involve converting the patient from VV ECMO to VAV ECMO by adding a peripheral arterial limb. This would provide the mechanical benefit of unloading the right and left heart, but can be technically challenging in the class 2 and 3 obese patient. The arterial limb can be placed percutaneously or open in a femoral artery, but this is subject to all of the associated challenges of femoral venous cannulation including difficult access and kinking. Additionally, the patient would require a distal perfusion cannula placed into the ipsilateral superficial femoral artery. This can be particularly challenging to perform reliably at the bedside in an obese patient. In this situation, we recommend using image guidance such as ultrasound or preferably, an angiogram in a hybrid operating room or catheterization lab. Because of the depth of soft tissue required to be transversed and to prevent inadvertent dislodgement we suggest using an extra-long wire-reinforced catheter. Alternatively, a retrograde reperfusion cannula can be placed in the posterior tibial artery where the soft tissue tends to be less extensive. Other surgical options for an arterial limb include tunneled cannulation of a graft sewn onto the axillary or femoral artery. It would obviate the need for a distal perfusion cannula, but the tunneled graft and cannula can kink in the soft tissue of class 2 or 3 patients. In the axilla, there is also a potential risk of brachial plexus compression from a deep hematoma that was not detected because of the patient's habitus. Additional options include transjugular pulmonary artery cannulation. This can be via either a 2-site technique that includes femoral venous drainage or making use of the ProTek Duo (Liva Nova), which is a dual-lumen cannula commonly placed in the right IJ vein, which bypasses the right ventricle. This cannula can be technically Figure E2 ). Patients with class 2 or 3 obesity initially receiving VV ECMO should continue to be ventilated with similar strategies outlined herein for the pre-ECMO phase. Reverse Trendelenburg bed positioning and use of an esophageal probe can optimize respiratory mechanics while accurately recreating rest settings per ARDS Net protocols. As lung recovery occurs, the sequence for weaning of the mechanical ventilator and ECMO should conform to the ECMO center's best practices. Specifically, if a center routinely manages VV ECMO patients without positive pressure ventilation, then the strategy can be applied to select patients with class 2 or 3 obesity. The potential advantages of liberating VV ECMO patients from mechanical ventilation include earlier mobilization, decreased sedation requirements, improved mentation, and improved respiratory muscle usage. 43 This would also apply to those with class 2 or 3 obesity. We would, however, caution against using these patients as the first cohort for trialing ECMO without a mechanical ventilator. Mobilizing patients with class 2 or 3 obesity while they are receiving ECMO can be rather challenging. Early tracheostomy could be a comprise by providing a protected airway while allowing for periods free from positive pressure ventilation. Acute lung injury in the patients with class 2 and 3 obesity can be difficult to manage particularly as a patient progresses to ARDS. Ventilator optimization might involve the use of an esophageal probe to measure P tp 's and where feasible, proning patients should be considered before initiating VV ECMO. However, if respiratory failure is refractory to conventional means, then mechanical circulatory support is a reasonable option in appropriately resourced and experienced centers. ECMO therapy for the class 2 and 3 obese patient population presents certain unique challenges that require thoughtful planning and meticulous execution of cannulation. Although ECMO cannulation can be a "routine" urgent procedure, it requires experienced cannulators with access to appropriate imaging. After ECMO is started, standard management practices might need to be adjusted to mitigate against mechanical and physiological challenges posed by obesity, including the need for increased flow. Mobilizing this patient population might be difficult, but it is possible and necessary to ensure a meaningful recovery. For patients with severe morbid obesity VV ECMO should be considered an option in experienced hands. Worsening right heart failure on VV ECMO 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 1195 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 1238 1239 1240 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 One caregiver raises the sling bar until there is tension in the straps, then the team confirms that all the required loops are secure in the sling bar Perfusionist is responsible for visualizing cannulas throughout the turn Ensure the team member at the head of the bed is responsible for initiating the turn maneuver via a verbal countdown, as well as securing the patients ETT and head throughout the maneuver. At this point, the patient is ready to be lifted On the count of 3, the caregiver on the side from which the patient is being turned away will operate the lift, while the other caregiver(s) monitor the lines and patient's response The caregiver at the head of bed will monitor and support the patient's head and airway. Caregivers at the foot of the bed are responsible for managing the LEs Upon lifting, the lift equipment will begin to rotate the patient to the side. The lift movement is slow and controlled Lift the patient high enough so they easily slide, but do not lift the patient fully off the bed. Slide patient to opposite side from which you are turning so they are centered when proned. The team should continue to manage tubing and lines as patient is being lowered Return ICU bed to normal mattress setting Before exiting the room, intensivist/APP to monitor vitals and assess patient's tolerance to position When returning the patient to the supine position, simply reconnect the ceiling lift to the bar in the same manner as when proning and follow the same procedures described above to return to supine position Please note, when returning the patient from prone to supine, ceiling lift used in lower portion of body should be inserted with care to avoid disturbing/ dislodging femoral cannula access Z-Flo is from M€ olnlycke Health Care. LE, ---; ETT, ---; ICU, intensive care unit; APP Q8 , ---. JTCVS Techniques c -2021 1347 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 1411 1412 1413 1414 1415 1416 1417 1418 1419 1420 1421 1422 1423 1424 1425 1426 1427 1428 1429 1430 1431 1432 1433 1434 1435 1436 1437 1438 1439 1440 1441 1442 1443 1444 1445 1446 1447 1448 1449 1450 1451 1452 1453 1454 1455 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 EDI 5.6.0 DTD XJTC960_proof 15 November 2021 6:12 pm ce CC JTCVS Techniques c Volume -, Number -13 1469 1470 1471 1472 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 1512 1513 1514 1515 1516 1517 1518 1519 1520 1521 1522 1523 1524 1525 1526 1527 1528 1529 1530 1531 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 14 JTCVS Techniques c -2021 1591 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 1637 1638 1639 1640 1641 1642 1643 1644 1645 1646 1647 1648 1649 1650 1651 1652 1653 1654 1655 1656 1657 1658 1659 1660 1661 1662 1663 1664 1665 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 1687 1688 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 1710 1711 Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) Score Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis Centers for Disease Control and Prevention. Defining adult overweight & obesity. Accessed People with certain medical conditions Regional distribution of pulmonary ventilation and perfusion in obesity The effects of body mass index on lung volumes The impact of morbid obesity on oxygen cost of breathing (VO(2RESP)) at rest Estimating blood volume in obese and morbidly obese patients Effects of obesity on cardiovascular hemodynamics, cardiac morphology, and ventricular function Pulmonary hypertension in obesity-hypoventilation syndrome ARDS in obese patients: specificities and management The association between supraphysiologic arterial oxygen levels and mortality in critically ill patients. A multicenter observational cohort study Association between arterial hyperoxia and mortality in critically ill patients: a systematic review and metaanalysis Effects of hyperoxia on oxygen-related inflammation with a focus on obesity Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome Effect of driving pressure on mortality in ARDS patients during lung protective mechanical ventilation in two randomized controlled trials Driving pressure and survival in the acute respiratory distress syndrome Impact of the driving pressure on mortality in obese and non-obese ARDS patients: a retrospective study of 362 cases Mechanical ventilation guided by esophageal pressure in acute lung injury Effect of titrating positive end-expiratory pressure (PEEP) with an esophageal pressure-guided strategy vs an empirical high PEEP-Fio2 strategy on death and days free from mechanical ventilation among patients with acute respiratory distress syndrome: a randomized clinical trial The promises and problems of transpulmonary pressure measurements in acute respiratory distress syndrome Effects of prone position and positive end-expiratory pressure on lung perfusion and ventilation Prone position improves lung mechanical behavior and enhances gas exchange efficiency in mechanically ventilated chronic obstructive pulmonary disease patients Prone positioning in severe acute respiratory distress syndrome Feasibility and effectiveness of prone position in morbidly obese patients with ARDS: a case-control clinical study Pitfalls in percutaneous ECMO cannulation Extremely obese patients treated with venovenous ECMO-an intensivist's challenge Veno-venous extracorporeal membrane oxygenation in obese surgical patients with hypercapnic lung failure Class III obesity is not a contraindication to venovenous extracorporeal membrane oxygenation support Direct complications of the Avalon bicaval dual-lumen cannula in respiratory extracorporeal membrane oxygenation (ECMO): single-center experience Physiology of gas exchange during ECMO for respiratory failure Parallel circuits for refractory hypoxemia on venovenous extracorporeal membrane oxygenation Opioid and benzodiazepine requirements in obese adult patients receiving extracorporeal membrane oxygenation Complications of prone positioning during extracorporeal membrane oxygenation for respiratory failure: a systematic review. Respir Care Tracheostomy is safe during extracorporeal membrane oxygenation support Postoperative complications in obese patients after tracheostomy Safety and feasibility of early physical therapy for patients on extracorporeal membrane oxygenator: University of Maryland Medical Center experience Feasibility and safety of early physical therapy and active mobilization for patients on extracorporeal membrane oxygenation The challenges faced with early mobilization of patients on extracorporeal membrane oxygenation Early mobilization of patients receiving extracorporeal membrane oxygenation: a retrospective cohort study Comparison of anticoagulation strategies in patients requiring venovenous extracorporeal membrane oxygenation: heparin versus bivalirudin Characteristics of patients managed without positive pressure ventilation while on extracorporeal membrane oxygenation for acute respiratory distress syndrome The authors reported no conflicts of interest.The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest.Illustrations were graciously provided by Andy Mattlock, Department of Surgery, Emory School of Medicine. The authors thank the Washington MedStar Healthsystem ECMO team and the Emory Healthcare ECMO team for their checklists and protocols.